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ABSTRACT
Objectives: Our study evaluates if the use of biological markers can predict the infertility in women with non-obstructive 
endometriosis.
Material and methods: Two prospective, non-randomised studies were conducted to identify if CA-125, IL-6 and IL-8 can be 
used as predictive markers for infertility in women with non-obstructive endometriosis. Peripheral levels of CA-125, IL-6 and 
IL-8 were measured before laparoscopy in all patients.
Results: We found a total number of 152 patients with non-obstructive endometriosis, we divided them in two groups: fertile 
and infertile women. There was a statistically significant difference of the mean of CA-125 values between the two groups 
(p = 0.00). The patients with infertility had a significantly higher IL-6 serum values than the fertile patients (p = 0.00). Regarding 
the IL-8 serum values, there was no statistically significant difference between the two groups fertile vs infertile, (p = 0.06).
Conclusions: The elevated serum levels of CA-125 and IL-6 was associated with an increased probability of being diagnosed 
with infertility. The IL-8 had no value in predicting infertility associated with non-obstructive endometriosis.
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INTRODUCTION
Endometriosis affects 10% of women of reproductive 
age and is defined as the presence of endometrial tissue 
(stroma and glands) outside the uterine cavity [1, 2]. Very 
often is difficult to diagnose the endometriosis disease in the 
general population, due to non-specific symptoms [3]. En-
dometriosis negatively impairs the quality of life in women, 
through the presence of symptoms including dysmenor-
rhea, dyspareunia, chronic pelvic pain, dyschezia and dysuria 
[4] Non-invasive diagnosis tests were highly researched 
for endometriosis disease and many biological markers 
have been tested from peripheral blood as biomarkers of 
endometriosis. The patients with endometriosis associate 
infertility in 30 to 50% of cases, and about 25 to 50% of 
infertile women are diagnosed with endometriosis [5, 6]. 
The etiopathogenesis of endometriosis involves several 
theories. However, two conditions are common: a chronic 
pelvic and systemic inflammation stimulating the perito-
neum secretion of cytokines and specifically Interleukin 
6 (IL-6) and Interleukin 8 (IL-8) [7]. It has been suggested 
that the autoimmune mechanisms may play an important 
role in infertility [8].
So far, most studies are evaluating the biomarkers in the 
non-invasive diagnosis of endometriosis however, there are no 
correlation of this biomarkers with infertility in this population. 
The aim of our study was to identify from peripheral 
blood frequent biomarkers correlated with endometriosis 
and infertility. CA 125 is the main biomarker along with pro-
inflammatory cytokines detected in endometriosis. Among 
serum cytokines IL-6 and IL-8 alone or in combination are 
known to be associate with endometriosis. Therefore, we 
hypothesized that this combination of IL-6 and IL-8 with 
serum CA125 levels will predict infertility in women with 
endometriosis with a superior value than CA 125 alone [7, 8].
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MATERIAL AND METHODS
After receiving the approval of the Commission for 
Medical Ethics (Filantropia Hospital) we started two stud-
ies. In the first study CA-125 was tested in 116 women with 
non-obstructive endometriosis and in the second, IL-6 and 
IL-8 were tested in 36 women. We collected plasma samples 
from women with non-obstructive endometriosis, prior to 
anesthesia induction, centrifuged at 4500 rpm for 5 minutes 
at 4°C, and stored at –70°C. The relevant information for 
each patient was collected in the electronic database. In 
each study patients were divided into two groups fertile 
and infertile women. The inclusion criteria were women 
with non-obstructive endometriosis, aged between 20 to 
45 years old. A total number of 152 women have met the 
inclusion criteria. Included patients were women in which 
surgery was indicated for endometriosis, infertility work-up 
or ovarian mass and endometriosis was assessed by the 
surgeon based on the direct visualization of typical macro-
scopic endometriosis lesions. Infertile women were patients 
who require assisted conception after failure to achieve 
a clinical pregnancy within 12 months or more of regular 
unprotected sexual intercourse. The exclusion criteria from 
our studies were: women who have been operated within 
3 months prior the sample collection, or with pelvic/sys-
temic inflammatory disease. No confounders factors were 
included in the study.
We conducted a case-control experimental study, in 
which two independent groups of fertile and infertile pa-
tients were identified and were compared in terms of CA-
125, IL-6 and IL-8 markers (Fig. 1). Because it was an experi-
mental study, there was no patient randomization process, 
the patients being assigned to the appropriate group based 
on the pathology or absence of the pathology.
A total of 116 patients with non-obstructive endo-
metriosis were enrolled in the first study. All patients had 
non-obstructive endometriosis detected intraoperatively. 
Preoperatively, peripheral blood samples were collected 
and processed according to the laboratory protocol. The 
surgical approach was by laparoscopy in 113 (97.41%) cases 
and by laparotomy in 3 (2.58%) cases due to technical dif-
ficulties. The patients were classified according to their fertil-
ity as follows: 22 patients with unknown fertility (18.96%), 
54 preserved fertility patients (46.55%), 36 patients with 
primary infertility (31.03%), 4 patients with secondary in-
fertility (3.44%).
After the exclusion of the patients with unknown fertility 
(n = 22), two groups were established, depending on the 
fertility status: fertile and infertile (with primary or second-
ary infertility).
 The data were processed statistically using IBM SPSS 18. 
Quantitative variables were described in terms of central 
tendency, dispersion, and their distribution. According to 
their distribution the Mann-Whitney U test or the Student 
test was used for comparison between groups, while either 
Spearman’s coefficient or Pearson’s coefficient was used to 
characterize the correlations between variables. In this study 
there were no missing values. 
RESULTS
Study 1. The role of CA-125 in predicting infertility 
associated with non-obstructive endometriosis
The mean age (± SD) of fertile patients was 36.69 (± 5.58), 
while the mean age (± SD) of those with infertility was 
36.43 (± 4.56). In the group of fertile patients, the youngest 
age was 25 years and the oldest age was 45 years, similar val-
ues being also observed in the group of those diagnosed as 
infertile (respectively 26 years, 45 years). Regarding the age 
there were no statistically significant differences between 
the two groups (p = 0.81 > 0.05). The American Society for 
Reproductive Medicine (ASRM) scoring system was used in 
Figure 1. Flow Chart of the study design for the two studies
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order to stage endometriosis as follows: 15 patients (12.93%) 
were enrolled in stage I, 57 patients (49.13%) in the stage II, 
30 patients (25, 86%) in stage III and 14 patients (12.06%) 
in stage IV. There was no statistically significant influence 
of the stage of endometriosis in fertility (p = 0.83 > 0.05). 
In the group of fertile patients, the mean values of CA-125 
(± SD) were 31.43 (± 19.98) and median was 24, while in the 
group of those diagnosed with infertility, the mean value 
(± SD) was 45.99 (± 30.37) and median 43.8 (Fig. 2). The 
distribution of CA-125 values in the group of fertile patients 
was non-parametric (p = 0.00 < 0.05) and parametric for the 
infertile patients’ group. There was a statistically significant 
difference of the mean values of the CA-125 between the 
two groups (p = 0.00). 
Study 2. The role of IL-6 and IL-8 in predicting 
infertility associated with non-obstructive 
endometriosis
A total of 36 patients with non-obstructive endometriosis 
were identified as meeting our inclusion criteria. Laparoscopy 
was the surgical approach in all patients. Regarding their re-
productive status, they were divided as follows: 22 (61.11%) 
women with infertility and 14 (38.88%) with normal fertility. 
Regarding the age of the enrolled women, the mean (± SD) 
age of the patients without fertility problems was 32.43 ± 7.73, 
and of those diagnosed with infertility was 30.82 ± 5.19, the 
medians being equal, respectively 31. In both groups, fertile 
and infertile, the distributions were non-parametric. In or-
der to see if the stage of endometriosis influenced fertility 
status, a Chi-square test was conducted. This showed that 
in our group there was a statistically significant influence of 
the stage of endometriosis on fertility (X2 = 23.19), p = 0.00.
The mean values of IL-6 (± SD) in fertile patients were 
5.79 ± 2.87 and the median was 6.01 and the infertility group 
the mean values was 91.88 ± 107.74 and the median was 
100. The statistical analysis of the IL-6 and IL-8 reveals that 
the mean value of IL-6 (± SD) was 38.38 ± 87.86 and the 
median of 10.5; Kolmogorov-Smirnov and Shapiro-Wilk nor-
mality tests reveals that the IL-6 values had a non-parametric 
distribution (p = 0 .00). 
For the IL 8, the mean value (± SD) was 12.54 ± 23.58 and 
the median of 1.6. Normality tests, Kolmogorov-Smirnov and 
Shapiro-Wilk, indicated a nonparametric distribution for 
IL-8 values. The correlation test (Spearman) demonstrates 
a statistically significant positive association (p = 0.00) be-
tween the two variables. The mean values of IL-8 (± SD) in 
fertile patients were 5.00 ± 8.01 and the median was 1.1 and 
in the infertility group 17.34 ± 28.59 respectively, with a me-
dian of 3.53. The distribution of the IL-8 values was non-para-
metric in both groups. Women with infertility had significantly 
higher IL-6 median values than fertile patients (p = 0.00). 
There was no statistically significant difference between the 
median of IL-8 values in the two groups (p = 0.06). The pre-
diction of a patient’s probability of being diagnosed with 
infertility, requires a logistic regression analysis: the sensitivity 
was 75% and the specificity 90%. The positive predictive value 
was 85.71% and the negative predictive value was 81.81%.
In our studies the exposure was the CA-125, IL-6 and 
IL-8 testing. We calculated the following parameters: the 
sensitivity was 68.75%, the specificity was 61.90%, the posi-
tive predictive value was 84.61% and the negative predictive 
value was 39.39%. After the statistical analysis we concluded 
that the CA-125 variable was the only one that contributed 
statistically significantly to this model (p = 0.01). The elevat-
ed values of this marker were associated with an increased 
probability of being diagnosed with infertility.
DISCUSSION AND CONCLUSIONS
Previous studies have demonstrated that the levels of 
cytokines and glycoproteins, are highly relevant for endome-
triosis, and an association of biomarkers represent non-in-
vasive tests for endometriosis [9]. The CA-125 is a peripheral 
biomarker of endometriosis, produced by endometrial and 
mesothelial cells [10]. The IL-6 and IL-8 have elevated periph-
eral levels in women with endometriosis [11–14].
The aim of our studies was to evaluate the role of bio-
markers in predicting infertility in patients with non-ob-
structive endometriosis. The peripheral blood biomarkers 
have been generally investigated for endometriosis, but 
not for non-obstructive endometriosis. Present data from 
the literature is controversial, with some studies demon-
strating elevated interleukins, IL-6 and IL8, in patients with 
endometriosis, while others have reported similar results in 
the endometriosis group versus control group [3, 4, 11, 13].
Through logistic regression, we tried to estimate the prob-
ability of a patient being infertile based of the CA-125 val-
ues. The CA-125 values were the only ones that contributed 
Figure 2. CA-125 values distribution in the two groups: fertile and 
infertile
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statistically significant to this model (p = 0.01), and the in-
crease of this marker was associated with an increase in the 
likelihood of being diagnosed with infertility. We conducted 
that the elevated CA-125 values increased the risk of infertility.
The stage of endometriosis influences the fertility sta-
tus. The statistical analysis of the second study suggests 
that the stage of endometriosis has a significant influence 
on fertility status (X2 = 23.19, p = 0.00), with a magnitude 
of effect measured by Phi and Cramer’s V very important. 
Practically, the advanced stages of endometriosis, even 
non-obstructive, can cause infertility through a mechanism 
other than the bilateral tubal obstruction. 
After the statistical analysis, the IL-6 was elevated in 
women with non-obstructive endometriosis and infertility 
(p = 0.00). The IL-8 did not show a statistical difference in 
non-obstructive endometriosis and there were no correla-
tions between fertility and the IL-8 levels.
The limitation of our studies was the number of patients 
and the fact that in the first study there was no signifi-
cant difference in the stage of endometriosis over fertility, 
whereas in the second study our results show that there is 
an influence. This statistical difference is due to the differ-
ent sample sizes.
These biomarkers of endometriosis are nonspecific in-
flammation associated proteins that reflect inflammatory 
changes also in other pathologies such as autoimmune 
disease, hepatitis, sepsis, pelvic inflammatory disease. Our 
findings could guide research to select a panel of cytokine 
with a better potential for diagnose in clinical practice. Fur-
thermore, the association of CA-125, IL-6 and IL-8 could 
improve diagnostic reliability.
Our data cannot be generalized, there is a need for 
a higher quality prospective studies and standardized 
approach, to draw firm conclusions regarding the role of 
biomarkers (CA-125, IL-6) in predicting infertility of women 
with non-obstructive endometriosis. This would provide 
more reliable and relevant information regarding this new 
hypothesis. 
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